CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
01/02/2023
Voltar para busca
Dado oficial do USPTO
FLEXREPORT
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
78
Atualização mais recente
01/02/2023
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
42, 44
Data de depósito
15/03/2018
Data de registro
06/09/2022
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
06/09/2022
Última transação
06/09/2022
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
15/04/2012
Primeiro uso no comércio
15/04/2012
Código do desenho
4
Tipo de titular
03
Localização do titular
Fort Myers, FL, US
Examinador
YANG, KATRINA
Unidade examinadora
N90
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
NeoGenomics Laboratories, Inc.
NeoGenomics Laboratories, Inc.
Representantes
Anessa O. Kramer Honigman LLP
Classificação técnica
Classes Nice
Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 42
Genetic mapping for scientific purposes; gene sequencing for scientific purposes; molecular sequencing for scientific purposes; scientific study and analysis in the field of cancer; clinical researchstudy and testing of cells; medical and scientific research information in the field of gene sequencingmolecular sequencingcancer study and analysisclinical study and testing of cells; scientific research in the field of gene sequencingmolecular sequencingcancer study and analysisclinical study and testing of cellscancer; providing medical research and scientific research information to others in the fields of oncologypathology and gene sequencingmolecular sequencingcancer study and analysisclinical study and testing of cells scientific testing and research services and clinical scientific testing; providing an internet website portal featuring gene sequencing for scientific purposesmolecular sequencing for scientific purposescancer study and analysisclinical study and testing of cells; scientific and medical research information in the fields of scientific testing and research servicesmedical research servicesclinical scientific testing; providing cloud-based scientific and medical research information to others in the field of scientific testing and research servicesmedical research servicesclinical scientific testing; providing temporary use of online non-downloadable software for analysis of medical test results; providing temporary use of online non-downloadable software for enhancement of analysisresearchreview of information pertaining to medicalscientificgenetictesting and analysisinformation and pertaining to such testing and analysis; software as a service (SAAS) services featuring software for analysis of medical test results; providing on-line non-downloadable computer software for enhancement of analysisresearchreview of information pertaining to medicalscientificgenetictesting and analysisinformation pertaining to testing and analysis; providing medical research and scientific research information in the field of oncology; genetic testingrna testing and sequencing for scientific purposes; scientific testing and research services in the field of human disease and human medical conditions; providing medical research services in the field of human disease and human medical conditions; providing clinical scientific testing services and medical research and testing in the field of human disease and human medical conditions; medical laboratory servicesclinical laboratory services and oncology reference laboratory servicesproviding medical research and scientific research information and reportsto others in the field of pathologydiagnostic testingoncology testing; providing an interactive website featuring information and reports in the field of scientific research in pathologydiagnostic testingoncology testing; consulting services in the fields of biotechnologypharmaceutical research and developmentlaboratory testingdiagnosticspharmacogenetics; medical and scientific researchconducting clinical trials for others; conducting research and clinical trials for others relating to medical devices and pharmaceuticals; medical laboratory servicesmedical oncology reference laboratory services
Classe 44
Medical diagnostic testing services in the field of human disease and human medical conditions; medical testing for diagnostic or treatment purposes; providing medical information to others in the field of human diseasehuman medical conditionsmedical diagnostic testing services and medical testing for diagnostic or treatment purposes; providing an Internet website portal featuring medical information in the field of human diseasehuman medical conditionsmedical diagnostic testing servicesmedical testing for diagnostic or treatment purposes; providing cloud-based medical information to others in the field of human diseasehuman medical conditionsmedical diagnostic testing servicesmedical testing for diagnostic or treatment purposes; medical testing for diagnostic or treatment purposes for the detection of cancer; medical testing for diagnostic or treatment purposes for the detection of genetic information pertaining to human disease; medical diagnostic testing to aid in diagnosisprognosis and therapy selection; providing information to others in the fields of pathologymedical diagnostic testing and oncology testinghuman disease and human medical conditions
Publicações
Histórico de despachos e eventos da marca no USPTO.
78 publicações encontradas
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/02/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/02/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/02/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
01/02/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
10/11/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/11/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/11/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/11/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
10/11/2022
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/09/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
06/09/2022
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
05/08/2022
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
04/08/2022
DOCK
ASSIGNED TO EXAMINER
13/07/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
13/06/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
13/06/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
13/06/2022
SUPC
STATEMENT OF USE PROCESSING COMPLETE
15/04/2022
IUAF
USE AMENDMENT FILED
13/04/2022
EISU
TEAS STATEMENT OF USE RECEIVED
13/04/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
13/10/2021
EX5G
SOU EXTENSION 5 GRANTED
12/10/2021
EXT5
SOU EXTENSION 5 FILED
06/10/2021
EEXT
SOU TEAS EXTENSION RECEIVED
06/10/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
16/04/2021
EX4G
SOU EXTENSION 4 GRANTED
15/04/2021
EXT4
SOU EXTENSION 4 FILED
12/04/2021
EEXT
SOU TEAS EXTENSION RECEIVED
12/04/2021
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
12/04/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/04/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/04/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/04/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
12/04/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
15/10/2020
EX3G
SOU EXTENSION 3 GRANTED
14/10/2020
EXT3
SOU EXTENSION 3 FILED
12/10/2020
EEXT
SOU TEAS EXTENSION RECEIVED
12/10/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
12/10/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/10/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/10/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/10/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
12/10/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
07/04/2020
EX2G
SOU EXTENSION 2 GRANTED
06/04/2020
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
03/04/2020
EXT2
SOU EXTENSION 2 FILED
01/04/2020
EEXT
SOU TEAS EXTENSION RECEIVED
01/04/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
01/04/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/04/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/04/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/04/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
01/04/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
15/10/2019
EX1G
SOU EXTENSION 1 GRANTED
11/10/2019
EXT1
SOU EXTENSION 1 FILED
11/10/2019
EEXT
SOU TEAS EXTENSION RECEIVED
11/10/2019
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
03/07/2019
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
16/04/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
19/02/2019
PUBO
PUBLISHED FOR OPPOSITION
19/02/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
30/01/2019
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
11/01/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/01/2019
XAEC
EXAMINER'S AMENDMENT ENTERED
11/01/2019
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
11/01/2019
GNEA
EXAMINERS AMENDMENT E-MAILED
11/01/2019
CNEA
EXAMINERS AMENDMENT -WRITTEN
11/01/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/12/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/12/2018
ALIE
ASSIGNED TO LIE
07/12/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/12/2018
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
28/06/2018
GNRT
NON-FINAL ACTION E-MAILED
28/06/2018
CNRT
NON-FINAL ACTION WRITTEN
28/06/2018
DOCK
ASSIGNED TO EXAMINER
26/06/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
22/03/2018
NWAP
NEW APPLICATION ENTERED
19/03/2018
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace FLEXREPORT ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.